Evidence map›Paper›PMID 39589884›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Structural basis of chiral wrap and T-segment capture by

Elizabeth Michalczyk, Zuzanna Pakosz-Stępień, Jonathon D Liston, Olivia Gittins, Marta Pabis, Jonathan G Heddle, Dmitry Ghilarov

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Structural and Computational Analysis ofbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elizabeth MichalczykDoctoral School of Exact and Natural Sciences, Jagiellonian University, Kraków 30-348, Poland.ORCID 0000-0002-9276-7764
Zuzanna Pakosz-StępieńCentre for Programmable Biological Matter, School of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, United Kingdom.ORCID 0000-0002-2288-8616
Jonathon D ListonCentre for Programmable Biological Matter, School of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, United Kingdom.ORCID 0000-0003-0283-8889
Olivia GittinsCentre for Programmable Biological Matter, School of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, United Kingdom.ORCID 0000-0002-3818-3952
Marta PabisMalopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0000-0001-7394-5206
Jonathan G HeddleMalopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0000-0003-0994-9928
Dmitry GhilarovDepartment of Molecular Microbiology, John Innes Centre, Norwich NR4 7UH, United Kingdom.ORCID 0000-0001-9325-3207

Funding

Leverhulme Trust International Professorship AwardNarodowe Centrum Nauki (NCN) 2020/39/B/NZ1/02898UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X01097X/1Wellcome TrustWellcome Trust (WT) 221868/Z/20/Z
6 · The paper itself

Abstract

Type II topoisomerase DNA gyrase transduces the energy of ATP hydrolysis into the negative supercoiling of DNA. The postulated catalytic mechanism involves stabilization of a chiral DNA loop followed by the passage of the T-segment through the temporarily cleaved G-segment resulting in sign inversion. The molecular basis for this is poorly understood as the chiral loop has never been directly observed. We have obtained high-resolution cryoEM structures of

Indexed as

DNA GyraseEscherichia coliMoxifloxacinCatalytic DomainCryoelectron MicroscopyDNA, BacterialDNA, SuperhelicalFluoroquinolonesModels, MolecularNucleic Acid ConformationTopoisomerase II InhibitorsDNA, BacterialDNA GyraseDNA, SuperhelicalFluoroquinolonesMoxifloxacinTopoisomerase II InhibitorsantibioticsDNA-binding proteinDNA crossovermolecular machinetopoisomerase

Identifiers

PMID39589884
PMCPMC11626157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.